These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31011967)

  • 1. Association of Pharmaceutical Manufacturer Payments to Physicians and Prescribing Dosage of Opioids.
    Fleischman W; Agrawal S; Gross CP; Ross JS
    J Gen Intern Med; 2019 Jul; 34(7):1074-1076. PubMed ID: 31011967
    [No Abstract]   [Full Text] [Related]  

  • 2. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.
    Zezza MA; Bachhuber MA
    PLoS One; 2018; 13(12):e0209383. PubMed ID: 30566426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
    DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
    JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
    Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries.
    Singh P; Forman H; Adamson AS; Mostaghimi A; Ogdie AR; Oganisian A; Barbieri JS
    J Gen Intern Med; 2019 Feb; 34(2):176-178. PubMed ID: 30324292
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.
    Hadland SE; Cerdá M; Li Y; Krieger MS; Marshall BDL
    JAMA Intern Med; 2018 Jun; 178(6):861-863. PubMed ID: 29799955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.
    Fleischman W; Agrawal S; King M; Venkatesh AK; Krumholz HM; McKee D; Brown D; Ross JS
    BMJ; 2016 Aug; 354():i4189. PubMed ID: 27540015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical payments to physicians may increase prescribing for opioids.
    Nguyen TD; Bradford WD; Simon KI
    Addiction; 2019 Jun; 114(6):1051-1059. PubMed ID: 30667135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology.
    Duarte-García A; Crowson CS; McCoy RG; Herrin J; Lam V; Putman MS; Ross JS; Matteson EL; Shah ND
    Mayo Clin Proc; 2022 Feb; 97(2):250-260. PubMed ID: 35120693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of Opioid-Related Industry Payments in Opioid Crisis Areas.
    Lee AJ; Bandari J; Macleod LC; Davies BJ; Jacobs BL
    J Gen Intern Med; 2019 Feb; 34(2):187-189. PubMed ID: 30402818
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses.
    Hadland SE; Rivera-Aguirre A; Marshall BDL; Cerdá M
    JAMA Netw Open; 2019 Jan; 2(1):e186007. PubMed ID: 30657529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industry Payments to Physicians for Opioid Products, 2013-2015.
    Hadland SE; Krieger MS; Marshall BDL
    Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Drugs Substitutes or Complements for Intensive (and Expensive) Medical Treatment.
    Zhang Y; Newhouse JP; Baicker K
    Am Econ Rev; 2011 May; 101(3):393-397. PubMed ID: 24058203
    [No Abstract]   [Full Text] [Related]  

  • 15. The Association between Industry Payments and Brand-Name Prescriptions in Otolaryngologists.
    Morse E; Hanna J; Mehra S
    Otolaryngol Head Neck Surg; 2019 Oct; 161(4):605-612. PubMed ID: 31547772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid manufacturer bribed doctors to prescribe fentanyl inappropriately, US says.
    Dyer O
    BMJ; 2016 Dec; 355():i6742. PubMed ID: 27979812
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between industry payments for opioid products and physicians' prescription of opioids: observational study with propensity-score matching.
    Inoue K; Figueroa JF; Orav EJ; Tsugawa Y
    J Epidemiol Community Health; 2020 Aug; 74(8):647-654. PubMed ID: 32350126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder Medications.
    Modi PK; Wang Y; Kirk PS; Dupree JM; Singer EA; Chang SL
    Urology; 2018 Jul; 117():50-56. PubMed ID: 29680480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare Part D payments for neurologist-prescribed drugs.
    De Lott LB; Burke JF; Kerber KA; Skolarus LE; Callaghan BC
    Neurology; 2016 Apr; 86(16):1491-8. PubMed ID: 27009256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industry Payments to Physicians and Prescriptions of Brand-Name Proton-Pump Inhibitors.
    Morse E; Fujiwara RJT; Mehra S
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):70-76. PubMed ID: 30325706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.